A proactive smoking cessation intervention in postpartum women

Jiménez-Muro, Adriana; Nerín, Isabel; Samper, Pilar; Marqueta, Adriana; Beamonte, Asunción; Gargallo, Pilar; Rodrı́guez, Gerardo

doi:10.1016/j.midw.2012.01.003

Cited by 24 publications

(22 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many postpartum interventions are predominantly psychosocial, such as support groups, 4 telephone sessions, 5 and web-based interventions. 6,7 Others are based on financial incentives [8][9][10] and nicotine replacement therapy.…”

Section: Introductionmentioning

confidence: 99%

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Allen

Lunos

et al. 2016

NICTOB

View full text Add to dashboard Cite

Introduction: Pregnancy is a strong motivator to quit smoking, yet postpartum relapse rates are high. Growing evidence suggests a role of sex hormones in drug abuse behavior and given the precipitous drop in sex hormones at delivery, they may play a role in postpartum relapse. This pilot study evaluates the feasibility and potential role of exogenous progesterone in postpartum smoking relapse. Methods: This 12-week double-blind placebo-controlled randomized pilot trial randomized 46 abstinent postpartum women to active progesterone (PRO; 200 mg twice a day) versus placebo (PBO) for 4 weeks. Participants were followed for relapse for 12 weeks. Main study outcomes include abstinence (point prevalence), feasibility (compliance per number of clinic visits attended, pill counts and Electronic Data Capture [EDC] completed) and self-reported acceptability. Safety was also measured by depressive symptom scores, adverse events, and breastfeeding. Results: Overall retention rate was 87% at week 12. At week 4, abstinence rates were 75% in the PRO group and 68.2% in the PBO group (p = .75). Medication adherence was 68% and clinic visit attendance was 80%, with no differences by randomization. Depressive symptom scores, adverse events, and breastfeeding did not vary by randomization. Conclusions: Although the study was not powered to evaluate abstinence rates, we did observe a higher prevalence of abstinence at week 4 in the PRO group. Further, exogenous progesterone was well tolerated and did not adversely affect depressive symptoms or breastfeeding. Thus, the results of this pilot study indicate further investigation into progesterone as a postpartum relapse prevention strategy is warranted. Implications: This innovative pilot trial determined the feasibility of delivering exogenous progesterone as a potential prevention of postpartum smoking relapse. We observed high retention and moderate adherence rates, as well as high acceptability among participants. Further, though not statistically significant, more women in the treatment group remained abstinent from smoking during follow-up. This project adds to the growing body of literature on the role of sex hormones in smoking relapse and also provides support for a fully powered clinical trial.

show abstract

Section: Introductionmentioning

confidence: 99%

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Allen

Lunos

et al. 2016

NICTOB

View full text Add to dashboard Cite

show abstract

“…Moreover, interacting with peer users can make it easier for drug use to appear normal, and the risk perception of substance use decreases, as noted by other authors (Neighbors et al, 2008;Chomynova et al, 2009;Jiménez-Muro et al, 2009;Peñafiel, 2009;Pedersen et al, 2013). This is particularly important among older students, since they are generally more exposed to use and its associated risks (Morales et al, 2011), in addition to the fact that they wish to experience new feelings and may have to cope with adverse situations (Sierra et al, 2005;Duarte et al, 2012).…”

Section: Discussionmentioning

confidence: 95%

“…In terms of risk perception, it has been found that marijuana users have a lower perception of its danger than non-users (Jiménez-Muro et al, 2009), not only as regards health consequences but also social and school performance (Kilemer, Hunt, Lee & Neighbors, 2007). Moreover, regular users have a lower perception of the hazards involved than experimental users (Chomynova, Miller & Beck, 2009).…”

Section: Factors Related To Marijuana Usementioning

confidence: 99%

Contextual factors associated with marijuana use in school population

Velázquez

Gamiño

Ito

et al. 2017

View full text Add to dashboard Cite

Introduction. Marijuana use among the student population has increased in Mexico and Latin America. There are social, interpersonal and individual factors associated with the onset and continuation of marijuana use. These include the availability of drugs in the community, opportunity for use, low perceived risk of harm from marijuana use and social tolerance by family and close friends. Moreover, these factors increase the probability of experimenting with other drugs, polysubstance use and dependence. Objective. To identify the relationship between the level of urbanization, drug availability, exposure to opportunity for use, risk perception and social tolerance of the level of marijuana use among Mexican middle and high school students. Method. The results are drawn from various surveys conducted in Mexico City and the National Survey of Drug Use among Students 2014. A total of 114 364 middle and high school students participated (49.8% boys and 50.2% girls). Results. Of the respondent 10.6% had used marijuana at least once (12.9% boys and 8.4% girls). The variables that predicted higher marijuana use were drug use approval by family and best friend,, the level of urbanization and low risk perception. Discussion and conclusion. Action must be taken on the factors mentioned to decrease the availability and use of drugs in the environment, and raise awareness of their consequences. These elements must be introduced systematically and creatively into preventive programs in this area.

show abstract

“…Although well received by patients, the intervention did not improve cessation outcomes compared to the control group. In contrast, Jiménez-Muro et al (2013) found a benefi cial effect for a brief telephone counseling smoking cessation intervention that started in the inpatient period and continued for 3 months afterward. Further testing of interventions for postpartum inpatient mothers is needed.…”

mentioning

confidence: 78%

Smoking Cessation and Relapse Challenges Reported by Postpartum Women

Yang

Hall

2014

McN: The American Journal of Maternal/Child Nursing

View full text Add to dashboard Cite

Current smokers need help quitting smoking and former smokers need postpartum relapse interventions. Providers should be intentional about offering existing interventions to help women quit smoking. Affordable and accessible interventions are needed that address unique stressors experienced by women, which include screening for depression and anxiety, and that incorporate smoking cessation interventions for spouses and partners who smoke. Cessation and relapse prevention interventions for postpartum women should start in the postpartum inpatient period and continue after discharge.

show abstract

A proactive smoking cessation intervention in postpartum women

Cited by 24 publications

References 46 publications

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial

Contextual factors associated with marijuana use in school population

Smoking Cessation and Relapse Challenges Reported by Postpartum Women

Contact Info

Product

Resources

About